Key facts
- PVH Corp. reported Q1 revenue of $2.025 billion but cut its full-year revenue outlook to flat.
- PVH Corp. shares dropped over 25% following the revised revenue outlook.
- Commvault Systems faces a securities fraud lawsuit after a 31% stock decline.
- Investors in Commvault Systems are urged to act by July 17, 2026.
- Oculis Holding AG shares fell over 23% after its OCS-01 DME program's Phase 3 DIAMOND trials failed.
- Rosen Law Firm is investigating POET Technologies Inc. for purchasers of securities between April 1, 2026, and April 27, 2026.
- Investors with losses exceeding $100,000 in POET Technologies have until June 29, 2026, to seek lead plaintiff status.
- Monteverde & Associates PC is investigating mergers involving CZNL, ESQ, GDOT, SEM, CZR, OMEX, SILA, and EVTV.
- The Schall Law Firm is investigating PVH Corp. officers and directors for potential breaches of fiduciary duty.
- Levi & Korsinsky is investigating Oculis Holding AG officers and directors.
A wave of investigations by various law firms targets numerous publicly traded companies for alleged securities fraud and breaches of fiduciary duty. PVH Corp. is under scrutiny after reporting Q1 revenue of $2.025 billion but cutting its full-year revenue outlook to flat, which caused its shares to drop over 25%. The Schall Law Firm is investigating potential breaches of fiduciary duty by PVH Corp.'s officers and directors.
Commvault Systems faces a securities fraud lawsuit and shareholder class action following a significant stock decline, reportedly 31%. Robbins LLP is urging investors who bought Commvault securities between April 29, 2025, and January 26, 2026, to contact the firm. The company allegedly failed to meet projected net new ARR growth due to an ARR mix shift, and investors are urged to act by July 17, 2026.
Oculis Holding AG is being investigated by Levi & Korsinsky after its OCS-01 DME program's Phase 3 DIAMOND trials failed. The company's shares fell over 23% amid allegations that SEC filings had described the program as on track for FDA submission despite the trial failure. Ademi LLP is investigating Via Transportation for potential securities fraud related to inaccurate statements about its financial statements and business operations.
Rosen Law Firm is reminding Stellantis N.V. investors of a securities fraud lawsuit for purchases made between February 26, 2025, and February 5, 2026, offering investors the opportunity to lead the lawsuit. Separately, Monteverde & Associates PC has launched legal inquiries into mergers involving CZNL, ESQ, GDOT, and SEM, as well as a separate merger involving CZR, OMEX, SILA, and EVTV. The firm, recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report, is investigating potential claims for shareholders harmed by these transactions, noting potential insider benefits not available to ordinary shareholders.
Several other companies are also facing investigations. Phreesia Inc. and Calix, Inc. shareholders who suffered losses may lead securities fraud class action lawsuits, with The Law Offices of Frank R. Cruz seeking lead plaintiffs for both cases. Rosen Law Firm is investigating securities fraud claims against POET Technologies Inc. for purchasers of POET securities between April 1, 2026, and April 27, 2026, with investors experiencing losses over $100,000 having the opportunity to lead the lawsuit by June 29, 2026. Sana Biotechnology, Inc. insiders face a probe for potential breaches of fiduciary duty, as do insiders at Five9, Inc. Wolf Haldenstein Adler Freeman & Herz LLP is investigating Sleep Number Corporation for potential securities fraud claims. Glancy Prongay Wolke & Rotter LLP is seeking lead plaintiffs for a securities fraud class action lawsuit against Sportradar Group AG. Rosen Law Firm is also investigating potential breaches of fiduciary duties by Manhattan Associates, Inc. directors and officers.
These investigations often involve allegations of misleading statements, failure to disclose material information, or actions that may have harmed shareholders, with many firms offering their services on a contingent fee basis and encouraging investors to contact them to discuss their rights and potential to lead class actions.